CClinicalTrials.gg
Status unknownNCT02850393SUPTOCUpdated Aug 1, 2016

Inhibitory Control of the Mind : Neural Bases and Impact for Obsessive-compulsive Disorders

An interventional study of Functional magnetic resonance imaging and behavioral measures in Obsessive Compulsive Disorder and Healthy, sponsored by University Hospital, Caen. Status unknown at 1 site in France. Open to participants aged 18 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-08-01.

Sponsored by University Hospital, Caen · Not applicable, Interventional, and Basic science

The sponsor has not verified this record recently (last verified Jul 2016), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
48
Allocation
Non-randomized
Ages
18 Years to 55 Years
Sex
All
01

Study summary

Mental-health conditions affect million people worldwide. The economic burden of mental illness is enormous and the economic health of both developing and developed nations will depend on controlling the staggering growth in costs from mental disorders. Obsessive-compulsive disorder (OCD) is a relatively common and frequent form of anxiety that affects approximately 2-3% of the population. OCD is characterized by anxiety, obsessions (persistent intrusive thoughts and images with highly distressing contents) and compulsions (repetitive activity), and severely impairs the lives of those affected. Despite their interest as effective and affordable care and rehabilitation, cognitive therapeutic profits too little from the increasing accumulation of knowledge in neuroscience, and neuroscientists pay too little attention to the challenges faced by clinical psychologists and psychiatrists. To reduce this cultural gap, two teams specialized in the study and multimodal imaging of healthy participants and clinical patients with mental health disorders, the UMR-S INSERM-EPHE-UNICAEN U1077 unit led by Francis Eustache, and ISTS team (UMR-S 6301 CNRS-CEA-UCBN) led by Sonia Dollfus, will joint their efforts to develop an integrated approach of the neural mechanisms at stake from basic neuroscience using state-of-art neuroimaging techniques, to novel and ground breaking psychological intervention. Both teams evolve at the brain imaging Cyceron center in Caen in connection with the Mental Health and Addictology Center, offering unique opportunities for such translational research. This project will capitalize on recent evidence showing that healthy participants can prevent unwanted images from entering consciousness using inhibitory control and memory suppression techniques, disrupting traces of the memories in sensory areas of the brain, and weakening their vividness and later reentrance. OCD is characterized by aberrant and excessive visual intrusions, usually extremely vivid, detailed, and unpleasant. These distressing images are particularly uncontrollable and may frequently initiate compulsive rituals. In a first phase of this proposal will use functional magnetic resonance imaging (fMRI) to develop a neurobiological model of the cognitive computations achieved by inhibition network to suppress memory. To achieve this goal we will develop an attentional model of healthy memory inhibition functioning, simulating the deployment of attentional resources and the different mental processes at stake during suppression. Using sophisticated analyzing tools of fMRI data, we will use this model to decode and infer the representational content of the brain inhibition network, and further refine the connectivity pathways which underlie such control. The lack of a strong neurobiological model prevents the development of therapies which would increase functionality of this network and optimize intervention aiming to disrupt mental intrusions and obsessions. In a second phase, we will assess whether memory suppression may be transferred and trained in OCD patients using images depicting their own obsessions, as a promising avenue to reduce their symptoms on the long run. In addition, fMRI and other brain structural acquisitions will be collected before and after cognitive training to memory suppression, offering a unique opportunity to observe the online dysfunction of intrusion control in OCD patients and to identify neurobiological markers predictive of training outcome and network reconfiguration with training. A fundamental goal of motivated forgetting involves not only to exclude unwelcome content from consciousness but also to reduce their later emotional impact by doing so. In parallel of these two main phases, we will thus also measure physiological markers of autonomic nervous system activity changes in response to suppressed images to better identify the consequences of memory suppression on emotional states, anxiety, and mental health in general.

02

Conditions studied

  • Obsessive Compulsive Disorder
  • Healthy

Keywords

  • suppression mnemonic
  • emotional response
  • inhibitory control of failures
  • neurological alterations
03

In context

Compulsive Personality Disorder

367 studies on the registry are indexed under Compulsive Personality Disorder; 67 are open to participants now.

This study's planned enrollment of 48 is above the median of 37 across 306 interventional studies indexed under Compulsive Personality Disorder.

Browse Compulsive Personality Disorder studies →

Lead sponsor

University Hospital, Caen is the lead sponsor of 505 studies on the registry; 80 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • All the participants :

    • Participants between 18 and 55 years old
    • Affiliated to the French national health care system
    • French native speaker
    • Right-handed
    • At least education after graduating with french GSCE "brevet des collèges"
    • Body mass \< 35kg/m2
  • Healthy subjects :

    • Signed written consent form
  • Patients :

    • Patients with OCD according to DSM V diagnostic criteria at the time of the study
    • Stabilized (no change of psychotropic drugs during the last 3 months)
    • Signed written consent form associated with the agreement of the tutor and / or curator for protected adults

Exclusion criteria

Exclusion Criteria:

  • All the participants :

    • Pregnancy or intent to get pregnant
    • Person deprived of their liberty
    • Person admitted to a health or social institution for purposes other than research
    • Minor
    • Protected adults or people unable to give informed consent
    • Person subjected to an exclusion period related to another protocol
    • History of cancer with the last 5 years, excluding squamous cell carcinomas
    • Alcoholism, antecedents of chronic alcoholism or drugs abuse
    • Use of medication that may interfere with cognitive or cerebral functioning
    • Presence of visual or hearing troubles that may compromise participant's ability to participate in the study
    • MRI Contraindications
  • Healthy subjects :

    • History of neurological or psychiatric disorders or existence of traumatic brain injury with loss of consciousness for more than one hour
    • Severe psychiatric disorders (according to DSM V diagnostic criteria) or psychological troubles which could affect participant's judgment
  • Patients :

    • Presence of neurological history, history of head trauma with loss of consciousness for more than an hour, severe depression, manic symptoms, post-traumatic stress, borderline personality disorder, antisocial, paranoid or schizoid.
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
48 participants (estimated)

Study arms

  • Experimental
    patients with obsessive compulsive disorder

    Functional magnetic resonance imaging behavioral measures physiological measurements

    Other: Functional magnetic resonance imaging · Behavioral: behavioral measures · Other: physiological measurements

  • Experimental
    healthy participants

    Functional magnetic resonance imaging behavioral measures physiological measurements

    Other: Functional magnetic resonance imaging · Behavioral: behavioral measures · Other: physiological measurements

Interventions

  • OtherFunctional magnetic resonance imaging
  • Behavioralbehavioral measures
  • Otherphysiological measurements
06

What researchers measure

Primary outcomes

  1. Blood Oxigen Level Dependent (BOLD) response as measured with fMRI

    Time frame: 1 hour

07

Study locations

1 site
  • GIP Cyceron
    Caen, Calvados 14000, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 1, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02850393
Lead sponsor
University Hospital, Caen
Collaborators
Institut National de la Santé Et de la Recherche Médicale, France, Centre National de la Recherche Scientifique, France, Université de Caen Normandie
Responsible party
Sponsor
First posted
Aug 1, 2016
Start date
Jul 2016
Primary completion
Mar 2019 (estimated)
Completion
Dec 2019 (estimated)
Last update
Aug 1, 2016

Study contacts

Anaïs Vandevelde, MD
principal investigator · University Hospital, Caen

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jul 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion